ArticleACS medicinal chemistry letters2026

Novel Compounds as GIPR Agonists for Treating Type 2 Diabetes Mellitus and Obesity.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.